Clinical data | |
---|---|
Trade names | Diprolene, Sernivo, Diprosone, others |
Other names | Betamethasone-17,21-dipropionate |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682799 |
License data | |
Pregnancy category |
|
Routes of administration | Topical |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.024.551 |
Chemical and physical data | |
Formula | C28H37FO7 |
Molar mass | 504.595 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Betamethasone dipropionate is a glucocorticoid steroid with anti-inflammatory and immunosuppressive properties. It is applied as a topical cream, ointment, lotion or gel (Diprolene) to treat itching and other skin conditions such as eczema. Minor side effects include dry skin and mild, temporary stinging when applied.[3] Betamethasone dipropionate is a "super high potency" corticosteroid used to treat inflammatory skin conditions such as dermatitis, eczema and psoriasis. It is a synthetic analog of the adrenal corticosteroids. Although its exact mechanism of action is not known, it is effective when applied topically to cortico-responsive inflammatory dermatoses.[4] It is available as a generic medication.[5]
drugs.com
was invoked but never defined (see the help page).